References
- Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT. Paracetamol poisoning. Brit Med J 1979; 2: 1097–1100.
- Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol 2009; 47: 81–88.
- Mant TGK, Tempowski JH, Volans GN, Talbot JCC. Adverse reactions to acetylcysteine and effects of overdose. Brit Med J 1984; 289:217–219.
- Ferner RE, Langford NJ, Anton C, Hutchings A, Bateman DN, Routledge PA. Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol 2001; 52: 573–577.
- Hayes BD, Klein-Schwartz W, Doyon S. Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother 2008; 42: 766–70.
- Mullins ME, Dribben WH, Halcomb SE, McCammon CA. Reducing dosing errors in IV acetylcysteine for acetaminophen poisoning. Ann Pharmacother 2008; 42: 1914–1915.
- Johnson MT, McCammon CA, Mullins ME, Halcomb SE. Evaluation of a simplified N-acetylcysteine dosing regimen for the treatment of acetaminophen toxicity. Ann Pharmacother 2011; 45: 713–720.
- http://www.clinicaltrials.gov/ct2/archive/NCT01118663 (last accessed Jan 14, 2011).
- Bates DW, Vanderveen T, Seger D, Yamaga C, Rothschild J. Variability in intravenous medication practices: implications for medication safety. Jt Comm J Qual Pat Saf 2005; 31:203–10.
- Lesar TS. Errors in the use of medication dosage equations. Arch Pediatr Adolesc Med 1998; 152: 340–44.
- Institute for Safe Medication Practices. Lack of standard dosing methods contributes to IV errors. ISMP Medication Safety Alert! Aug 23, 2007. http://www.ismp.org/Newsletters/acutecare/articles/20070823.asp (accessed Jan 9, 2011).
- Larsen GY, Parker HB, Cash J, O'Connell M, Grant MC. Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients. Pediatrics 2005; 116: e21–e25.
- Bailey B, Blais R, Letarte A. Status epilepticus after a massive intravenous N-Acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med 2004; 44:401–406.
- Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Giffin SL. 2008 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol 2009; 47: 911–1084.
- Heard K, Schaeffer TH. Massive acetylcysteine overdose associated with cerebral edema and seizures. Clin Toxicol 2011; 49: 423–425.
- Levine L, Cowan KM, Osler AG, Mayer MM. Studies on the role of Ca + + and Mg + + in complement fixation and immune hemolysis: I. Uptake of complement nitrogen by specific precipitates and its inhibition by ethylene diamine tetra acetate. J Immunol 1953; 71: 359–366.
- Rapp HJ, Borsos T. Effects of low ionic strength on immune hemolysis. J Immunol 1963; 91: 826–832.
- Schnitzer RJ, Pundsack FL. Asbestos hemolysis. Environ Res 1970; 3:1–13.
- Becton, Dickinson & Co. BD Vacutainer® evacuated blood collection system. 11/2010 http://www.bd.com/vacutainer/pdfs/blood_collection_tubes_product_insert_VDP40035.pdf (accessed 28 February 2011).
- Wright RO, Perry HE, Woolf AD, Shannon MW. Hemolysis after acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency. J Toxicol Clin Toxicol 1996; 34:731–734.
- Ruha AM, Selden B, Curry S. Hemolytic anemia after acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency. Am J Med 2001; 110:240–241.
- Sklar GE. Hemolysis as a potential complication of acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency. Pharmacotherapy 2002; 22:656–658.
- Korpi-Steiner NL, Hoyne JB, Hoyer JD, Saenger AK. Hemolytic anemia following attempted suicide. Clinical Chemistry 2008; 54:2071–2075.
- Beutler E. G6PD deficiency. Blood 1994; 84: 3613–3636.
- Kamerbeek NM, van Zwieten R, de Boer M, Morren G, Vuil H, Bannink N, . Molecular basis of glutathione reductase deficiency in human blood cells. Blood 2007; 109: 3560–3566.
- Caprari P, Caforio MP, Cianciulli P, Maffi D, Pasquino MT, Tarzia A, . 6-Phosphogluconate dehydrogenase deficiency in an Italian family. Ann Hematol 2001; 80: 41–44.
- Szeinberg A, Marks PA. Substances stimulating glucose catabolism by the oxidative reactions of the pentose phosphate pathway in human erythrocytes. J Clin Invest 1961; 40:914–25.
- Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of trombotic thrombocytopenic purpura. J Am Soc Nephrol 2003; 14:1072–1081.
- Levy GG, Motto DG, Ginsbure D. ADAMTS 13 turns 3. Blood 2005; 106:11–17.
- Sadler EJ. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenia purpura. Blood 2008; 112: 11–18.
- Noris M, Remuzzi G. Atypical Hemolytic-Uremic Syndrome. New Engl J Med 2009; 361:1676–1687.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–245.
- Garcia-Cortes M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ, and the Spanish Group for the Study of Drug-Induced Liver Disease. Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 2008; 27: 780–789.